Abstract: The fiber-reinforced resin material of the present invention is a fiber-reinforced resin material having a laminated structure in which fiber assembly layers and thermoplastic resin layers are alternately located, wherein the fiber assembly layers are each an assembly of continuous fibers having thermoplastic resin particles attached to surfaces thereof, and the fiber-reinforced resin material has a higher elongation on one surface side than that on the other surface side. The fiber-reinforced resin structure is made of the present fiber-reinforced resin material. A method for manufacturing the present fiber-reinforced resin material includes: a stacking step of stacking a sheet-shaped product of the continuous fibers that serves as the fiber assembly layer and a resin sheet that serves as the thermoplastic resin layer so as to obtain the laminated structure; and a hot-pressing step of heating and compressing a stacked product obtained through the stacking step in a stacking direction.

Abstract: Semiconductor nanoparticles including Ag, In, Ga, and S are provided. In the semiconductor nanoparticles, a ratio of a number of Ga atoms to a total number of In and Ga atoms is 0.95 or less. The semiconductor nanoparticles emit light having an emission peak with a wavelength in a range of from 500 nm to less than 590 nm, and a half bandwidth of 70 nm or less, and have an average particle diameter of 10 nm or less.

Abstract: Provided is a thermoplastic elastomer composition for an impact-resistant material, comprising a block copolymer composition comprising a block copolymer (B) in which a functional group capable of noncovalent bonding is introduced into a block copolymer (A) including at least one aromatic vinyl polymer block and at least one conjugated diene polymer block.

Abstract: An endoscope observation assistance apparatus includes an image information acquiring part to acquire and display a captured image of a luminal organ captured by the endoscope device on a display, a lesion information acquisition part to detect a predetermined lesion based on the captured image and to acquire lesion information regarding the lesion, a lesion disappearance determination part to track the lesion based on the captured image and the lesion information and to determine whether or not the lesion has disappeared from the captured image, and a notification part to notify a determination result when the lesion disappearance determination part determines that the lesion has disappeared from the captured image. Alternatively, the notification part may notify a lesion detection when a short time period passes after the lesion detection by the lesion information acquisition part.

Abstract: A communication device that can prevent the transmission of a message from being continuously hindered over a long period of time, a communication system and a message arbitration method are provided. The communication device transmits and receives a message to and from another device connected to a common communication line which comprises a calculation unit that calculates as to a message to be transmitted a margin time before a time when a transmission of the message is completed; a transmission unit that transmits the message to which information related to the margin time calculated by the calculation unit is attached; and an arbitration unit that performs arbitration based on the information attached to the message when simultaneous message transmissions to the communication line occur, and as to multiple of messages simultaneously transmitted to the communication line, the arbitration unit performs arbitration in such a manner as to prioritize a message with a shorter margin time.

Abstract: A soil-borne plant disease control agent that can be safely used as a biopesticide. The active component of the control agent includes viable bacteria of novel strains of Bacillus and Fictibacillus, or a culture of these bacteria. The soil-borne plant disease control agent is a vegetable wilt control agent. The plant disease control agent can be applied (sprayed) to stems and leaves to control a bacterial wilt disease caused by soil bacteria Ralstonia solanacearum species complex, and/or bacterial soft rots. A plant disease control method.

Abstract: The present disclosure relates to methods for depositing vertically oriented carbon nanowalls (CNWs) using non-equilibrium gases such as gaseous plasma. Methods are disclosed for rapid deposition of uniformly distributed nanowalls on large surfaces of substrates using ablation of bulk carbon materials by reactive gaseous species, formation of oxidized carbon-containing gaseous molecules, ionization of said molecules and interacting said molecules, neutral or positively charged, with a substrate. The CNWs prepared are useful in different applications such as fuel cells, lithium ion batteries, photovoltaic devices and sensors of specific gaseous molecules.

Abstract: The present invention addresses the problem of providing a fundamental therapeutic method for renal diseases including glomerulonephritis such as IgA nephropathy. To solve this problem, the present invention pertains to an agent for increasing CD25-positive regulatory T cells in kidney, said agent comprising mesenchymal stem cells. The regulatory T cell-increasing agent of the present invention exerts a sufficient therapeutic effect even if further containing a cryopreservation liquid at a concentration of less than 5% (v/v).

Abstract: A carbon dioxide recovery device provided with a separation device that separates carbon dioxide from to-be-separated gas (for example, combustion exhaust gas) containing carbon dioxide, wherein: in order from the upstream side where the to-be-separated gas is supplied, the separation device and carbon dioxide sublimators, which sublimate (solidify) carbon dioxide that was separated in the separation device, are connected in series, refrigerant circuits in which a fluid having cold heat serves as the refrigerant, are connected to the carbon dioxide sublimators, and the refrigerant is used to sublimate (solidify) the carbon dioxide; and when the carbon dioxide is sublimated (solidified), the carbon dioxide sublimators are depressurized and set to negative pressure so as to draw in the carbon dioxide separated at the separation device.

Abstract: Provided is a method of producing semiconductor nanoparticles exhibiting band-edge emission with a short emission peak wavelength. The method of producing semiconductor nanoparticles comprises: obtaining a first mixture that contains a Ag salt, an In salt, a compound containing Ga and S, and an organic solvent; and performing a heat treatment of the first mixture at a temperature in a range of 125° C. or higher and 300° C. or lower to obtain first semiconductor nanoparticles.

Abstract: Semiconductor nanoparticles including Ag, In, Ga, and S are provided. In the semiconductor nanoparticles, a ratio of a number of Ga atoms to a total number of In and Ga atoms is 0.95 or less. The semiconductor nanoparticles emit light having an emission peak with a wavelength in a range of from 500 nm to less than 590 nm, and a half bandwidth of 70 nm or less, and have an average particle diameter of 10 nm or less.

Abstract: An image processing apparatus according to an embodiment includes a processing circuitry. The processing circuitry acquires pixel values of at least three different types of magnetic resonance (MR) images. The processing circuitry causes a display to display a diagram in which values based on the pixel values are arranged in a region with at least three-dimensional axes.

Abstract: An information processing apparatus specifies a vector representation which represents features of respective temporal usage patterns of two or more areas. The information processing apparatus includes a processor. The processor acquires area-specific usage pattern data which indicates which of two or more patterns the temporal usage pattern of each area is. The processor specifies, on the basis of the area-specific usage pattern data, a vector representation which represents the feature of the temporal usage pattern of each area.

Abstract: A nucleoside derivative represented below, or a salt thereof. (In (1), R1 represents a hydrogen atom, a hydroxyl group or a protected group, and in (2), X represent a halogen atom. In (1) and (2), R2 and R4 each represent a hydrogen atom, a hydroxyl protecting, phosphate, or protected phosphate group, or —P(?O)nR5R6 (n is 0 or 1, R5 and R6 each representing a hydrogen atom, hydroxyl, protected hydroxyl, mercapto, protected mercapto, lower alkoxy, cyano lower alkoxy, amino or substituted amino group, when n is 1, R5 and R6 are not both hydrogen atoms), R3 represents NHR7 (R7 represents a hydrogen atom, alkyl, alkenyl or protecting group for an amino group), an azide, amidino or guanidino group, each having a linking group (when R7 is hydrogen atom, the linking group is an alkylene group), and B represents any of a purine-9-yl, 2-oxo-pyrimidin-1-yl, substituted purine-9-yl or substituted 2-oxo-pyrimidin-1-yl group).

Abstract: The present invention provides a method for efficiently separating and purifying functional pituitary hormone-producing cells and/or progenitor cells thereof from differentiated tissues derived from pluripotent stem cells.

Abstract: Provided is a method of producing semiconductor nanoparticles that exhibit a band-edge emission, and are superior in quantum yield. The method includes raising the temperature of a first mixture containing a silver (Ag) salt, a salt containing at least one of indium (In) and gallium (Ga), a solid compound that serves as a supply source of sulfur (S), and an organic solvent to a temperature in a range of from 125 ?C to 175 ?C, and heat-treating, subsequent to the raising of the temperature, the first mixture at a temperature in a range of from 125 ?C to 175 ?C for three seconds or more to obtain a solution containing semiconductor nanoparticles, and decreasing the temperature of the solution containing semiconductor nanoparticles. The solid compound that serves as a supply source of S contains thiourea.

Abstract: Provided is a method that allows for a safer production of a naphthylsilole for use as a starting material for GNR, which involves reacting a compound of formula (1): (wherein R1a and R1b are the same or different and represent a hydrogen atom, an alkyl group, a cycloalkyl group, a (poly)ether group, an ester group, a halogen atom, an aromatic hydrocarbon group, or a heterocyclic group; R1a and R1b are optionally bound to each other to form a ring; R2 represents an aromatic hydrocarbon ring or a heterocyclic ring; and X represents a bromine or iodine atom) with a lanthanide- and lithium-containing ate complex to produce a lanthanide complex of the compound of formula (1); and then reacting it with a silyl compound of formula (2): R3aR3bSiCl2??(2) (wherein R3a and R3b are the same or different and represent an optionally branched C1-C4 alkyl group or a phenyl group).

Abstract: A diagnostic imaging support device includes: a learning unit that calculates a feature quantity about each of infectiousness condition and non-infectiousness condition for determining a condition in a determination image of an anterior eye through machine learning on the basis of a learning image of an anterior eye and information about a condition in the learning image.

Abstract: A control device includes a model generation unit that generates a control model that formulates a task to be executed, and a task processing unit that causes the vehicle to execute the task by performing model prediction control using the control model. Assuming that a first state space is a state space of the control model used at an execution time of the first task, and a second state space is a state space of the control model used at an execution time of the second task, the task processing unit starts to cause the vehicle to execute the second task, after executing a transition process that is a process of making a value of a state variable that is commonly included in both the first state space and the second state space within a predetermined range that is allowed at the execution time of the second task.

Abstract: An anti-MEFLIN antibody and a pharmaceutical composition comprising the antibody is described. The pharmaceutical composition may comprise an antibody-drug conjugate (ADC) of the anti-MEFLIN antibody and a cytotoxic agent, which may be connected to each other by a linker. The pharmaceutical composition may be used in the treatment of a cancer in a subject.